Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations. (Q38616806)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

Fernanda Rodrigues-Soares

28 February 2020

author

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Fernando De Andrés

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Marisol López-López

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Adrián Llerena

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Adrián Llerena

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

8

E Peñas-Lledó

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

I Fricke-Galindo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

C Céspedes-Garro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

M E G Naranjo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Á Delgado

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

27 October 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

113-123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/tpj.2015.70

28 February 2020

exact match

0 references

cites work

Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

CYP2C19*17 affects R-warfarin plasma clearance and warfarin INR/dose ratio in patients on stable warfarin maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Prevalence and significance of CYP2C19*2 and CYP2C19*17 alleles in a New Zealand acute coronary syndrome population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Newly identified synergy between clopidogrel and calcium-channel blockers for blood pressure regulation possibly involves CYP2C19 rs4244285.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

A combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Molecular basis of ethnic differences in drug disposition and response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

The great human expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

A high incidence of polymorphic CYP2C19 variants in archival blood samples from Papua New Guinea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Analysis of Sepik populations of Papua New Guinea suggests an increase of CYP2C19 null allele frequencies during the colonization of Melanesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Evidence for the polymorphic oxidation of debrisoquine and proguanil in a Khmer (Cambodian) population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Hydroxylation index of omeprazole in relation to CYP2C19 polymorphism and sex in a healthy Iranian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic polymorphism of CYP2D6 and CYP2C19 in east- and southern African populations including psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Polymorphic oxidative metabolism of proguanil in a Nigerian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Cytochrome P450 2C19 genetic polymorphisms in Ugandans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Characterization of the genetic profile of CYP2C19 in two South African populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Inactive alleles of cytochrome P450 2C19 may be positively selected in human evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Allele and genotype frequencies of CYP2B6 and CYP2C19 polymorphisms in Egyptian agricultural workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Determination of CYP2C19 phenotype in black Americans with omeprazole: correlation with genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic polymorphism of cytochrome P450 2C19 in Mexican Americans: a cross-ethnic comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Prevalence of CYP2C19 polymorphisms in the Lebanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic Polymorphism of Cytochrome p450 (2C19) Enzyme in Iranian Turkman Ethnic Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genotype-phenotype analysis of CYP2C19 in healthy saudi individuals and its potential clinical implication in drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Distribution of CYP2C19*2 and CYP2C19*3 polymorphisms in Venezuelan populations with different admixture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Frequencies of Functional Polymorphisms in Three Pharmacokinetic Genes of Clinical Interest within the Admixed Puerto Rican Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Relationship between proguanil metabolic ratio and CYP2C19 genotype in a Caucasian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Association between blood carisoprodol:meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Pharmacogenetically relevant polymorphisms in Portugal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Microarray-based detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 allele frequencies in native Russians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Allele and genotype frequency of CYP2C19 in a Tamilian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Evaluation of the activity of CYP2C19 in Gujrati and Marwadi subjects living in Mumbai (Bombay)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic variations and haplotypes of the 5' regulatory region of CYP2C19 in South Indian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Polymorphisms of MDR1, CYP2C19 and P2Y12 genes in Indian population: effects on clopidogrel response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Phenotype analysis of cytochrome P450 2C19 in Chinese subjects with mephenytoin S/R enantiomeric ratio in urine measured by chiral GC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Analysis of the CYP2C19 polymorphism in a North-eastern Thai population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

High-throughput detection of multiple genetic polymorphisms influencing drug metabolism with mismatch primers in allele-specific polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Comparisons of CYP2C19 genetic polymorphisms between Korean and Vietnamese populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Identification of new CYP2C19 variants exhibiting decreased enzyme activity in the metabolism of S-mephenytoin and omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

CYP2C19 haplotypes in Koreans as a marker of enzyme activity evaluated with omeprazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Pharmacogenetic polymorphisms in Brazilian-born, first-generation Japanese descendants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Analysis of 50 SNPs in CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP1A2 by MALDI-TOF mass spectrometry in Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic polymorphisms and novel allelic variants of CYP2C19 in the Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

A systematically combined genotype and functional combination analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in different geographic areas of mainland China--a basis for personalized therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Multiple regression analysis of pharmacogenetic variability of carvedilol disposition in 54 healthy Japanese volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Proguanil metabolism in relation to S-mephenytoin oxidation in a Turkish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Mephenytoin hydroxylation in the Cuna Amerindians of Panama

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

CYP2C19‐ and CYP3A4‐Dependent Omeprazole Metabolism in West Mexicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Frequency of impaired mephenytoin 4'-hydroxylation in an Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Dapsone N-acetylation, metoprolol alpha-hydroxylation, and S-mephenytoin 4-hydroxylation polymorphisms in an Indonesian population: a cocktail and extended phenotyping assessment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

A rapid and simple LC–MS/MS method for the simultaneous evaluation of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 hydroxylation capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Reproducibility over Time of Mephenytoin and Debrisoquine Hydroxylation Phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Frequency of S-mephenytoin hydroxylation deficiency in 373 spanish subjects compared to other Caucasian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

Distribution of CYP2C Polymorphisms in an Amerindian Population of Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

21 January 2018

12 December 2020

CYP2C19 activity comparison between Swedes and Koreans: effect of genotype, sex, oral contraceptive use, and smoking

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2015.70

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences

21 January 2018

1 reference

12 December 2020

Evidence for the effect of gender on activity of (S)-mephenytoin 4'-hydroxylase (CYP2C19) in a Chinese population.

1 reference

12 December 2020

Genetic polymorphism of debrisoquine (CYP2D6) and proguanil (CYP2C19) in South Pacific Polynesian populations

1 reference

12 December 2020

Genetic polymorphism of the hepatic cytochrome P450 2C19 in north Indian subjects

1 reference

12 December 2020

Population pharmacology and ethnopharmacokinetics in 3 Amerindian groups from Panama: Cuna, Ngawbe Guaymi and Teribe

1 reference

12 December 2020

Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population

1 reference

12 December 2020

Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China

1 reference

12 December 2020

S-mephenytoin hydroxylation phenotypes in a Jordanian population

1 reference

12 December 2020

High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands.

1 reference

12 December 2020

Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole

1 reference

12 December 2020

Association between CYP2C19 polymorphism and depressive symptoms

1 reference

12 December 2020

Phenotyping of CYP2C19 with enantiospecific HPLC-quantification of R- and S-mephenytoin and comparison with the intron4/exon5 G-->A-splice site mutation.

1 reference

12 December 2020

Prevalence of CYP2C19 polymorphisms involved in clopidogrel metabolism in Fujian Han population

1 reference

12 December 2020

Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population

1 reference

12 December 2020

Assessment of CYP2C19 genetic polymorphisms in a Korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles

1 reference

12 December 2020

Genetic polymorphism analysis of cytochrome P4502C19 in Chinese Uigur and Han populations

1 reference

12 December 2020

Debrisoquine and S-mephenytoin hydroxylation polymorphisms in a Russian population living in Estonia

1 reference

12 December 2020

S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin

1 reference

12 December 2020

Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agents

1 reference

12 December 2020

Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations

1 reference

12 December 2020

Phenotyping polymorphic drug metabolism in the French Caucasian population

1 reference

12 December 2020

Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population

1 reference

12 December 2020

The hydroxylation of omeprazole correlates with S-mephenytoin and proguanil metabolism

1 reference

12 December 2020

Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population

1 reference

12 December 2020

Evidence for the polymorphic oxidation of debrisoquine and proguanil in a New Zealand Maori population

1 reference

12 December 2020

Canadian Native Indians exhibit unique CYP2A6 and CYP2C19 mutant allele frequencies*

1 reference

12 December 2020

Linkage of mutant alleles of CYP2C18 and CYP2C19 in a Japanese population

1 reference

12 December 2020

Single nucleotide polymorphism genotyping of CYP2C19 using a new automated system

1 reference

12 December 2020

Proguanil disposition and toxicity in malaria patients from Vanuatu with high frequencies of CYP2C19 mutations

1 reference

12 December 2020

Genetic polymorphism of CYP2C19 in Maharashtrian population

1 reference

12 December 2020

Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese

1 reference

12 December 2020

Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes

1 reference

12 December 2020

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man

1 reference

12 December 2020

Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations

1 reference

12 December 2020

Allele frequency of CYP2C19 in a Portuguese population

1 reference

12 December 2020

CYP2C19 genotype and phenotype determined by omeprazole in a Korean population

1 reference

12 December 2020

Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population

1 reference

12 December 2020

Frequency distribution of high risk alleles of CYP2C19, CYP2E1, CYP3A4 genes in Haryana population

1 reference

12 December 2020

Cyp2c19 genotype and omeprazole hydroxylation phenotype in Chinese Li population

1 reference

12 December 2020

Genetic analysis of the S-mephenytoin polymorphism in a chinese population*

1 reference

12 December 2020

CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit population

1 reference

12 December 2020

Distribution of CYP2C19*17 allele and genotypes in an Indian population

1 reference

12 December 2020

Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem.

1 reference

12 December 2020

Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia

1 reference

12 December 2020

Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population

1 reference

12 December 2020

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism

1 reference

12 December 2020

Debrisoquin and S-mephenytoin hydroxylation phenotypes and CYP2D6 genotypes in an Estonian population

1 reference

12 December 2020

Prevalence of CYP2C19 gene polymorphisms in the Puerto Rican population: a preliminary report.

1 reference

12 December 2020

Evidence that poor metabolizers of (S)-mephenytoin could be identified by haplotypes of CYP2C19 in Japanese

1 reference

12 December 2020

Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele

1 reference

12 December 2020

The mephenytoin (cytochrome P450 2C 19) and dextromethorphan (cytochrome P450 2D6) polymorphisms in Saudi Arabians and Filipinos

1 reference

12 December 2020

CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations

1 reference

12 December 2020

Allele frequency differences of cytochrome P450 polymorphisms in a sample of New Zealand Māori.

1 reference

12 December 2020

CYP2C19 genetic polymorphism in Saudi Arabians

1 reference

12 December 2020

Identifiers

DOI

10.1038/TPJ.2015.70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26503820%20AND%20SRC:MED&resulttype=core&format=json